CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-29 | Seshadri Vishwas Chief Executive Officer | Sale | −19,608 | $5.16 | $101K | 1,286,500 |
| 2026-09-29 | Vazzano Joseph Walter Chief Financial Officer | Sale | −9,191 | $5.16 | $47K | 482,888 |
| 2026-09-29 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −6,727 | $5.16 | $35K | 421,226 |
| 2026-09-29 | Vasanthavada Madhav Chief Commercial Officer | Sale | −4,902 | $5.16 | $25K | 285,721 |
| 2026-09-01 | Alvino Mark Director | Sale | −15,000 | $5.86 | $88K | 62,065 |
| 2026-07-21 | Vazzano Joseph Walter Chief Financial Officer | Sale | −1,478 | $6.53 | $10K | 492,079 |
| 2026-07-09 | Vazzano Joseph Walter Chief Financial Officer | Sale | −24,880 | $6.96 | $173K | 493,557 |
| 2026-07-09 | Seshadri Vishwas Chief Executive Officer | Sale | −67,971 | $6.96 | $473K | 1,306,108 |
| 2026-07-09 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −12,050 | $6.96 | $84K | 427,953 |
| 2026-07-09 | Vasanthavada Madhav Chief Commercial Officer | Sale | −12,606 | $6.96 | $88K | 290,623 |
| 2026-06-30 | Alland Leila Director | Sale | −11,000 | $5.92 | $65K | 162,614 |
| 2026-06-16 | Vasanthavada Madhav Chief Commercial Officer | Other disposition | −222 | $5.67 | $1K | 303,229 |
| 2026-06-15 | Silverstein Christine Berni Director | Sale | −18,160 | $5.71 | $104K | 119,562 |
| 2026-06-09 | Vazzano Joseph Walter Chief Financial Officer | Sale 10b5-1 | −13,421 | $5.30 | $71K | 544,083 |
| 2026-06-09 | Vazzano Joseph Walter Chief Financial Officer | Sale 10b5-1 | −25,646 | $5.39 | $138K | 518,437 |
| 2026-06-09 | Vasanthavada Madhav Chief Commercial Officer | Sale | −5,450 | $5.30 | $29K | 303,451 |
| 2026-06-09 | Seshadri Vishwas Chief Executive Officer | Sale | −31,916 | $5.30 | $169K | 1,374,079 |
| 2026-06-09 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −6,305 | $5.30 | $33K | 440,003 |
| 2026-06-08 | Vazzano Joseph Walter Chief Financial Officer | Sale 10b5-1 | −10,271 | $5.43 | $56K | 557,504 |
| 2026-06-08 | Vasanthavada Madhav Chief Commercial Officer | Sale | −4,170 | $5.43 | $23K | 308,901 |
Page 1 of 12 · 223 trades